The Food and Drug Administration yesterday revised its April 3 emergency use authorization for N95 and similar respirators made in China to remove certain respirators that failed to demonstrate at least 95% particulate filtration efficiency when tested by the National Institute for Occupational Safety and Health. Health care personnel should not use these respirators as personal protective equipment but may use them as face masks, FDA said. The unauthorized models are made by: CTT Co. Ltd; Daddybaby Co. Ltd; Dongguan Xianda Medical Equipment Co. Ltd.; Guangdong Fei Fan Mstar Technology LTD; Guangdong Nuokang Medical Technology Co. Ltd.; Huizhou Huinuo Technology Co. Ltd.; and Lanshan Shendun Technology Co.

Related News Articles

Perspective
As we move into fall and winter, we know the viruses that cause respiratory disease will usually circulate more heavily in communities. Already, the Centers…
Headline
In these video snippets from an AHA Advancing Health podcast series, health care leaders and clinicians from four children's hospitals share how they worked to…
Headline
Most health insurers must cover the updated COVID-19 vaccines from Pfizer and Moderna without cost sharing effective Sept. 11, when the Food and Drug…
Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
AHA is providing its latest social media toolkit to help hospitals encourage vaccination against COVID-19. The newest toolkit includes messages and assets…